FDA Investigator Michael G Sinkevich

Michael G Sinkevich has conducted inspections on 450 sites in 3 countries as of 08 Jul 2013. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
450
Last Inspection Date:
08 Jul 2013
Investigator Role:
FDA Investigator
Redica ID:
100005917
Countries of Inspections:
United States of America, India, Korea (Republic of)
FDA Investigators that have inspected at least one site in common with Michael G Sinkevich:
Alan R Condon, Aldo J Milone, Alia Legaux, Alice C Silva, Alois P Provost, Alysia M Salonia, Alyssa R Favro, Amanda T Zick, Amy Kim, Amy Wyan Mai, Andrew F Cohen, Andrew M Abramowitz, Andrew M Barlow, Ann B Okon, Anne Marie Dubrey, Anthony N Onianwa, Arthur F Walker, Arthur G Hurst, Arthur S Williams, Jr, Ava M Bowman, Benton M Ketron, Betty M Ng Lee, Bruce G Cooper, Carl A Huffman, III, Carolyn J Cook, Catherine M Beer, Charisse K Green, Christian Parra, Dana A Razzano, Darrell A Collins, Dave M Deroche, David A Laplante, David M Mcnew, David R Delucia, Denise L Burosh, Denise L Terzian, Diamond M Oden, Diane M Fresch, Dipesh K Shah, Dolores Harper, Donald G Gordon, Donald J Ullstrom, Dr. Abhijit Raha, PhD, Dr. Gopa Biswas, PhD, Dr. Sriram Subramaniam, PhD, Edmund F Mrak, Jr, Ellen M Landis, Erin L Nagel, Evelyn Taha, Felix Maldonado, Frank J Koch, Gabriel Davila, Gary T Greco, George C Amedro, Gerard D Difiore, Gregson A Joseph, Irina Gaberman, Isaac N Baah, Jacobson, Jacqueline S Warner, James R Wormuth, James W Whitney, Jamie S Mathews, Jane C Chen, Jeffery A Hangartner, Joanne M Schlossin, Joel R Powers, John A Hollings, Jonah S Ufferfilge, Jonathan B Lewis, Jonathan D Green, Jonathan G Matrisciano, Joseph Maselli, Joseph T Frost, Joshua D Lopez, Joshua L Gibbs, Joy P Matthias, Joyce A Williams, Juan Rjimenez Garcia, Juanita P Versace, Judy Keihl, Julie Scoma, Kara A Scheibner, PhD, Karen L Kosar, Kathleen E Mcafoose, Kenneth G Klobus, Kerun Hardeo, Kevin A Gonzalez, Kham Phommachanh, Kimberly M White, Kimberly Y Smithson, Kwong P Lee, Laura L Bechard, Lawrence H Patrick, LCDR Chad N Thompson, Leena Thomas, Lenita R Silvera, Lirissia Mccoy, Lisa M Romano, Lisa Mathew, Loretta J Miller, Makini Cobourne Duval, PhD, Margaret E Sarles, Marie Elena C Puleo, Marlene L Davis, Mary M Finn, Matthew D Schnittker, Meghan L Fetterly, Meisha A Mandal, Melissa A Henaghan, Melissa N Gregorio, Meredith P Soehl, Investigator, Michael A Charles, Michael F Skelly, PhD, Michael R Dominick, Michelle L Dragon Nagel, Milan S Mcgorty, Mohsen Rajabi Abhari, FDA, Muralidhara B Gavini, PhD, Nancy A Saxenian Emmons, Nicholas C Mendiola, Pankaj H Amin, Parul M Patel, Paul A Bonneau, Paul E Stein, Paul M Gelfand, Perez, Perry T Nichols, Peter M Trunk, Peter R Caparelli, Rajiv R Srivastava, Randi Lynn Bodoh, Randi Lynn Spencer, Rebecca B Welch, Rebecca C Brown, Richard W Berning, Robert J Altobelli, Robert J Veitch, Russ E Davis, Samuel M Salerno, Sarah Forney, Sasha M Latonis, Satheesh Thomas, Scott B Laufenberg, Scott M Loughan, Scott R Izyk, Seongeun Cho (Julia), PhD, Sherona A Ryder, Shreya Shah, Sripal R Mada, PhD, Stanley E Malcolm, Steven J Libal, Tamara M Simpson, Tania K Mercado, Tanya R Syffrard, Tara K Normandin, Tessa M Geary, Tessa M Latham, Thomas Cote, Thomas J Mooney, Thomas O Morgan, Todd A Manning, Troy R Petrillo, Victoria Taylor, Walter H Stanley, Wayne J Meyer, Wayne S Thompson, Wendy A Johnecheck, Wendy M Stone, Weston K Szymanski, William M Rennells, William P Chilton, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yiying E Chen, Yiyue Zhang (nmi), PhD, Yvonne M Santiago

Michael G Sinkevich's Documents

Publish Date Document Type Title
December, 2000 FDA 483 Kendall a Division of Tyco Healthcare Group LP - Form 483, 2000-12-21
May, 2004 EIR ICON Development Solutions, LLC - EIR, 2004-05-27
September, 2001 FDA 483 Kendall a Division of Tyco Healthcare Group LP - Form 483, 2001-09-13
April, 2011 FDA 483 Bates Industries, L.L.C. - Form 483, 2011-04-07
May, 2005 FDA 483 Angiodynamics Inc. (Navilyst Medical Inc.) - Form 483, 2005-05-06
February, 2012 FDA 483 William M. Kufs, MD - Form 483, 2012-02-15
September, 2012 FDA 483 Moss Tubes Inc. - Form 483, 2012-09-21
October, 2000 FDA 483 Moss Tubes Inc. - Form 483, 2000-10-16
January, 2003 FDA 483 Stratton VA Medical Center Transfusion Service (113c) - Form 483, 2003-01-03
February, 2013 FDA 483 Hyperbaric Technologies Inc. - Form 483, 2013-02-20
June, 2001 FDA 483 Fulton Village Purveyors - Form 483, 2001-06-27
July, 2003 EIR CARGILL INCORPORATED - EIR, 2003-07-10
May, 2009 FDA 483 Hyperbaric Technologies Inc. - Form 483, 2009-05-12
February, 2003 FDA 483 Kendall a Division of Tyco Healthcare Group LP - Form 483, 2003-02-05
January, 2003 EIR James Arthur Holland - EIR, 2003-01-03
February, 2003 FDA 483 Response Kendall a Division of Tyco Healthcare Group LP - Form 483R, 2003-02-20
May, 2004 FDA 483 ICON Development Solutions, LLC - Form 483, 2004-05-27
October, 2010 FDA 483 The Phantom Laboratory Inc - Form 483, 2010-10-12
June, 2001 EIR Fulton Village Purveyors - EIR, 2001-06-27
May, 2011 FDA 483 American Bio Medica Corp - Form 483, 2011-05-18
December, 2001 EIR Central Connecticut Cooperative Farmers Association - EIR, 2001-12-12
October, 2000 EIR Moss Tubes Inc. - EIR, 2000-10-16
October, 2000 FDA 483 Response Moss Tubes Inc. - Form 483R, 2000-11-08
May, 2013 FDA 483 Robert Bosch Heathcare Systems Inc - Form 483, 2013-05-22

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more